EXTENDING LEADING EDGE SOLUTIONS TO GOVERNMENTS, CORPORATIONS AND INSTITUTIONS AROUND THE WORLD

Pasadena, CA, October 24, 2022 – Pasadena, CA. Innova Medical Group, Inc. (“Innova”), a global leader in antigen testing, announced that it has received from the United States Food and Drug Administration (“FDA”) a letter formally closing out the Warning Letter originally sent to the company on June 10, 2021. This close-out letter was received…

Pasadena, CA, May 5, 2022 – Innova Medical Group, Inc., a global health screening and diagnostic innovator and a world leader in the manufacturing and distribution of COVID-19 rapid tests, along with Attomarker, a nanophotonic biochemical testing company spun from the University of Exeter in the United Kingdom, announced today that the two companies have formed…

A New Industrial facility in France, in the Centre-Val de Loire region In October 2021, the Innova Medical Group inaugurated its first rapid antigen test production line in France, in Pithiviers, Loiret, in the heart of Europe’s leading pharmaceutical cluster, Polepharma, which is also headquartered in Centre-Val de Loire. Accompanied in its search for industrial…

Pasadena, CA – December 14, 2021– As a leading provider of COVID-19 testing solutions, Innova Medical Group understands the importance of community. This holiday season, Innova and its leadership help make wishes come true for children in communities where we operate by supporting the Make-A-Wish Foundation with a US$100,000 donation from Innova and a US$50,000…